Adventris Pharmaceuticals
Adventris makes cancer vaccines
Adventris Pharmaceuticals is a company in healthcare based in Baltimore, MD, USA.
Profile
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.
If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Adventris Pharmaceuticals is positioned in healthcare, a segment that rewards a clear, focused offering.
Baltimore, MD, USA is where the company is located.
It is recorded at the Winter 2023 stage.
The company reports a headcount in the 7 range.
Directory analysis
Adventris Pharmaceuticals is a small U.S. biotech based in Baltimore that develops off‑the‑shelf cancer vaccines targeting poorly immunogenic oncogenes. Its first product focuses on the KRAS oncogene, the most common driver in many cancers. The company envisions a future where pan‑cancer vaccines are administered annually to prevent the majority of cancer deaths.
Positioning: As an early‑stage player, Adventris offers a niche oncology platform that could differentiate itself if it demonstrates clinical efficacy, though it remains to be seen whether the technology will translate into marketable therapies.
Note: Adventris is developing KRAS‑targeted cancer vaccines.
Auto-generated directory analysis from public data · updated 12 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | Baltimore, MD, USA |
| Country | USA |
| Employees | 7 |
| Stage | Winter 2023 |
Website: adventris.com
Browse related
Create a free account